Genetic testing doesn't treat sexual dysfunction — it maps the biological terrain that every treatment decision operates within. The Precision Peptide Genetic Test delivers 6 Sexual Health insights across 14 pathways, 49 peptides, and 150+ genetic insights, giving providers the upstream biological context that bloodwork alone cannot supply — and changing the clinical conversation before any protocol begins.

In the Precision Peptide Genetic Test, the Sexual Health pathway delivers 6 insights across the genes governing central arousal, vascular sexual response, desire, bonding, and circadian sexual timing. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 6 variants map sexual biology as a connected system — not a checklist of isolated traits.

Libido has a genetic architecture — DRD2 receptor density, OXTR bonding sensitivity, MTNR1B circadian timing, and MC4R central arousal signaling all shape sexual desire at the neurochemical level. The Precision Peptide Genetic Test maps these variables as part of 14 pathways, 49 peptides, and 150+ genetic insights, explaining the biology of desire that testosterone panels miss.

Erectile function depends on multiple gene-governed systems — nitric oxide production, central arousal signaling, dopamine-driven desire, and cGMP preservation. The Precision Peptide Genetic Test maps the key variants across 14 pathways, 49 peptides, and 150+ genetic insights, identifying the genetic architecture that testosterone panels and vascular tests alone cannot reveal.

Sexual wellness has a genetic architecture — six biological variables that determine how your body produces arousal, routes blood flow, generates desire, and responds to intimacy. The Precision Peptide Genetic Test maps all six as part of 14 pathways, 49 peptides, and 150+ genetic insights, answering the question that hormone panels and bloodwork alone cannot.

DRD2 encodes the D2 dopamine receptor that governs the motivation, anticipation, and reward dimensions of sexual desire. The Precision Peptide Genetic Test analyzes DRD2 variants as part of 14 pathways, 49 peptides, and 150+ genetic insights — mapping the neurochemical foundation of sexual drive that no testosterone panel captures.

The Precision Peptide Genetic Test analyzes 6 Sexual Health insights covering the four systems behind sexual response — vascular (eNOS, PDE5), dopamine (DRD2), bonding (OXTR), and circadian (MTNR1B) — within 14 pathways, 49 peptides, and 150+ genetic insights. This pillar breaks down what each gene reveals and why sexual health is a multi-system problem.